← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
13therapeutics, Inc.
Portland, OR
$7,085,555
Total funding
5
Grants
Funding over time
peak $1.3M · FY2006–14$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$6,038,900 · 4
DOD$1,046,655 · 1
By mechanism
R44$5,598,875 · 2
—$1,046,655 · 1
R21$340,781 · 1
R43$99,244 · 1
Investigators at 13therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A NOVEL THERAPEUTIC FOR THE TREATMENT AND PREVENTION OF HEARING LOSS FROM ACOUSTIC TRAUMA$1,046,655
· FY2014 · Department of Defense
Bacterial-Induced Sepsis: A New Treatment Strategy$999,605
R44 · FY2011 · AI
Bacterial-Induced Sepsis: A New Treatment Strategy$999,411
R44 · FY2013 · AI
Bacterial-Induced Sepsis: A New Treatment Strategy$996,265
R44 · FY2012 · AI
New Treatment for Inflammation in Middle Ear Infections$790,418
R44 · FY2008 · DC
New Treatment for Inflammation in Middle Ear Infections$706,451
R44 · FY2007 · DC
Bacterial-Induced Sepsis: A New Treatment Strategy$400,791
R44 · FY2007 · AI
Bacterial-Induced Sepsis: A New Treatment Strategy$393,525
R44 · FY2008 · AI
New Treatment for Inflammation in Middle Ear Infections$312,409
R44 · FY2006 · DC
Limiting Inflammation in Bacterial Meningitis by Targeting Host Immune Pathways$187,500
R21 · FY2007 · AI
Limiting Inflammation in Bacterial Meningitis by Targeting Host Immune Pathways$153,281
R21 · FY2008 · AI
Bacterial-Induced Sepsis: A New Treatment Strategy$99,244
R43 · FY2006 · AI